NCT06223009View on ClinicalTrials.gov

Phase 1 Healthy Volunteer Burn Therapy Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

May 6, 2024

Study Completion Date

July 23, 2024

Conditions
Burns
Interventions
DRUG

cNP8

cNP8 for injection is provided as a sterile lyophilizate for solution for infusion. Subjects will receive a single 30 minute IV infusion of cNP8 at their assigned dose.

OTHER

Placebo

Subjects not randomized to cNP8 will receive a single 30 minute IV infusion of placebo.

Trial Locations (1)

55114

Nucleus Network, Saint Paul

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Neomatrix Therapeutics, Inc.

OTHER

NCT06223009 - Phase 1 Healthy Volunteer Burn Therapy Study | Biotech Hunter | Biotech Hunter